SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Vascular Biogenics Q1 EPS $(0.150) Beats $(0.170) Estimate, Sales $366.000K Beat $160.000K Estimate

Vascular Biogenics (NASDAQ:VBLT) reported quarterly losses of $(0.150) per share which beat the analyst consensus estimate of $(0.170) by 11.76 percent. This is a 25 percent decrease over losses of $(0.120) per share

Benzinga · 05/14/2020 11:03

Vascular Biogenics (NASDAQ:VBLT) reported quarterly losses of $(0.150) per share which beat the analyst consensus estimate of $(0.170) by 11.76 percent. This is a 25 percent decrease over losses of $(0.120) per share from the same period last year. The company reported quarterly sales of $366.000 thousand which beat the analyst consensus estimate of $160.000 thousand by 128.75 percent. This is a 67.12 percent increase over sales of $219.000 thousand the same period last year.